Cart
sales@molnova.com
Dimethyl itaconate
CAS No. 617-52-7
Dimethyl itaconate ( —— )
Catalog No. M20124 CAS No. 617-52-7
Dimethyl Itaconate is a chemical reagent used in the synthesis of functionalized 2-isoxazolines used in fragment-based drug discovery.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 48 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 42 | Get Quote |
|
| 100MG | 61 | Get Quote |
|
| 200MG | 88 | Get Quote |
|
| 500MG | 149 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDimethyl itaconate
-
NoteResearch use only not for human use.
-
Brief DescriptionDimethyl Itaconate is a chemical reagent used in the synthesis of functionalized 2-isoxazolines used in fragment-based drug discovery.
-
DescriptionDimethyl Itaconate is a chemical reagent used in the synthesis of functionalized 2-isoxazolines used in fragment-based drug discovery.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number617-52-7
-
Formula Weight158.15
-
Molecular FormulaC7H10O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC(=O)CC(=C)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2,4,6-tribromobenzen...
2,4,6-tribromobenzene-1,3,5-triol is a marine derived natural products found in Rhabdonia verticillata.
-
GPR183
GPR183 is a chemotactic receptor known for its role in the maturation of B cells, and the endogenous ligand is the oxysterol 7α,25-dihydroxycholesterol (7α,25-OHC). GPR183 can be used in research on inflammatory bowel disease (IBD).
-
Agmatine sulfate sal...
Agmatine sulfate is a bioactive metabolite of the arginine amino acid. It exerts modulatory action at multiple molecular targets such as neurotransmitter systems ion channels and nitric oxide synthesis. It is an endogenous agonist at imidazoline receptor and a NO synthase inhibitor.
